Use of 20-hete synthesizing enzyme inhibitors as therapy for...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/155 (2006.01) A61K 31/145 (2006.01) A61K 31/15 (2006.01) A61K 31/20 (2006.01) A61K 31/4164 (2006.01) A61K 31/4174 (2006.01) A61K 31/4192 (2006.01) A61K 39/395 (2006.01) A61K 48/00 (2006.01) A61P 9/10 (2006.01) A61P 25/00 (2006.01) A61P 25/06 (2006.01) A61P 25/28 (2006.01) A61P 31/00 (2006.01)

Patent

CA 2427557

A method for treating cerebral vascular diseases in a human or non-human animal is disclosed. The method involves inhibiting 20-HETE synthesizing enzyme activity sufficiently to increase or prevent a decrease in cerebral blood flow in the human or non-human animal. This can be obtained by treating the animal with inhibitors of CYP4A or CYP4F family of enzymes, such as HET0016, 17-ODYA (17-octadecynoic acid), DDMS (dibromododecenyl methylsulfimide), 1-ABT (1-aminobenzotriazole) and miconazole, or with an antibody to 20-HETE synthetizing enzyme or with an antisense oligo-nucleotide directed against 5' end of CYP4A1, CYP4A2, CYP4A11, CYP4F2 or CYP4F3.

L'invention concerne une méthode de traitement de maladies vasculaires cérébrales chez des animaux humains et non humains. La méthode consiste à inhiber suffisamment l'activité d'une enzyme de synthèse de 20-HETE, de manière à accroître le flux sanguin cérébral chez l'animal humain ou non humain ou à empêcher une baisse dudit flux.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of 20-hete synthesizing enzyme inhibitors as therapy for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of 20-hete synthesizing enzyme inhibitors as therapy for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 20-hete synthesizing enzyme inhibitors as therapy for... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1918315

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.